Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

By Braida D.   Pozzi M.   Parolaro D.   Sala M.  

European Journal of Pharmacology, Vol. 413, Iss. 2, 2001-02 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats

By Norwood C.S.   Cornish J.L.   Mallet P.E.   McGregor I.S.  

European Journal of Pharmacology, Vol. 465, Iss. 1, 2003-03 ,pp. : 105-114

Elsevier

Access to resources Recommend Favorite

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine

By Arnold J.C.   Topple A.N.   Hunt G.E.   McGregor I.S.  

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 9-16

Elsevier

Access to resources Recommend Favorite

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices

By Gifford A.N.   Samiian L.   Gatley S.J.   Ashby Jr. C.R.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 187-192

Elsevier

Access to resources Recommend Favorite

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB 1 receptor characterization, distribution, and G-protein activation

By Darmani N.A.   Sim-Selley L.J.   Martin B.R.   Janoyan J.J.   Crim J.L.   Parekh B.   Breivogel C.S.  

European Journal of Pharmacology, Vol. 459, Iss. 1, 2003-01 ,pp. : 83-95

Elsevier

Access to resources Recommend Favorite